4//SEC Filing
Moukheibir Catherine 4
Accession 0001213900-22-024303
CIK 0001821586other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:47 PM ET
Size
5.8 KB
Accession
0001213900-22-024303
Insider Transaction Report
Form 4
Moukheibir Catherine
Director
Transactions
- Award
Option to Buy
2022-04-06+45,000→ 45,000 totalExercise: $12.25Exp: 2032-04-06→ Class A ordinary shares, par value $0.0001 per share (45,000 underlying)
Footnotes (1)
- [F1]Ms. Moukheibir was granted 45,000 options on April 6, 2022 pursuant to the MoonLake Immunotherapeutics 2022 Equity Incentive Plan (the "Plan"), vesting one-third on each of April 6, 2023, April 6, 2024 and April 6, 2025, in each case, subject to the terms of the Plan. Each option represents the right to acquire one Class A ordinary share, par value $0.0001 per share, of the Issuer.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001772130
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:47 PM ET
- Size
- 5.8 KB